Question 1

What are the main types of parenteral drug delivery systems?

Accepted Answer

Parenteral drug delivery systems include injectables, implants, and infusion devices. Injectables comprise solutions, dispersions, microspheres, and nanoparticles that control drug release through various mechanisms. Implants are surgically inserted solid devices for long-term drug release, while infusion devices like osmotic pumps and battery-powered pumps deliver precise doses through mechanical or electronic means.

Question 2

How do injectable solutions control drug release?

Accepted Answer

Injectable solutions regulate drug release through viscosity changes, complexation, or partitioning behavior. These mechanisms modify how quickly the drug dissolves and becomes available in the bloodstream. By adjusting formulation properties, solutions enable sustained therapeutic levels while minimizing fluctuations in drug concentration.

Question 3

Why are microspheres particularly useful for protein and peptide delivery?

Accepted Answer

Microspheres composed of biodegradable polymers protect proteins and peptides from enzymatic degradation while enabling sustained delivery. The polymer matrix gradually breaks down, releasing the drug over extended periods. This approach maintains therapeutic action and reduces the frequency of injections needed for biologics.

Question 4

What role do semipermeable membranes play in osmotic pumps?

Accepted Answer

Osmotic pumps use semipermeable membranes to create pressure gradients that drive controlled drug release. Water enters the pump chamber through the membrane, generating osmotic pressure that propels the drug at a steady, predictable rate. This mechanism enables precise dosing for conditions requiring meticulous dose control.

Question 5

How do dispersed systems like emulsions and suspensions regulate drug release?

Accepted Answer

Dispersed systems control drug release through droplet or particle size and the physical and chemical properties of the formulation. Oil-based dispersions further enable sustained drug action by slowing dissolution and absorption. These formulations allow customization of release rates based on therapeutic requirements.

Question 6

What are the key material requirements for implantable drug delivery devices?

Accepted Answer

Implantable devices must demonstrate stability, biocompatibility, and sometimes removability. These properties ensure the device functions safely within the body over extended periods without triggering adverse reactions. Material selection is critical for chronic conditions requiring consistent dosing over months or years.

Question 7

How do parenteral delivery systems improve patient outcomes?

Accepted Answer

Parenteral systems enhance bioavailability, reduce the need for frequent dosing, minimize systemic side effects, and improve patient compliance. By maintaining therapeutic drug concentrations over time and bypassing the gastrointestinal tract, these systems provide consistent treatment for poorly absorbed or unstable oral medications.

Парентеральные системы доставки лекарственных средств: инъекционные формы, имплантаты и инфузионные устройства